RESUMO
In settings requiring synthetic data generation based on a clinical cohort, e.g., due to data protection regulations, heterogeneity across individuals might be a nuisance that we need to control or faithfully preserve. The sources of such heterogeneity might be known, e.g., as indicated by sub-groups labels, or might be unknown and thus reflected only in properties of distributions, such as bimodality or skewness. We investigate how such heterogeneity can be preserved and controlled when obtaining synthetic data from variational autoencoders (VAEs), i.e., a generative deep learning technique that utilizes a low-dimensional latent representation. To faithfully reproduce unknown heterogeneity reflected in marginal distributions, we propose to combine VAEs with pre-transformations. For dealing with known heterogeneity due to sub-groups, we complement VAEs with models for group membership, specifically from propensity score regression. The evaluation is performed with a realistic simulation design that features sub-groups and challenging marginal distributions. The proposed approach faithfully recovers the latter, compared to synthetic data approaches that focus purely on marginal distributions. Propensity scores add complementary information, e.g., when visualized in the latent space, and enable sampling of synthetic data with or without sub-group specific characteristics. We also illustrate the proposed approach with real data from an international stroke trial that exhibits considerable distribution differences between study sites, in addition to bimodality. These results indicate that describing heterogeneity by statistical approaches, such as propensity score regression, might be more generally useful for complementing generative deep learning for obtaining synthetic data that faithfully reflects structure from clinical cohorts.
Assuntos
Pontuação de Propensão , Humanos , Aprendizado Profundo , Algoritmos , Simulação por ComputadorRESUMO
Growing industrial utilization of enzymes and the increasing availability of metagenomic data highlight the demand for effective methods of targeted identification and verification of novel enzymes from various environmental microbiota. Xylanases are a class of enzymes with numerous industrial applications and are involved in the degradation of xylose, a component of lignocellulose. The optimum temperature of enzymes is an essential factor to be considered when choosing appropriate biocatalysts for a particular purpose. Therefore, in silico prediction of this attribute is a significant cost and time-effective step in the effort to characterize novel enzymes. The objective of this study was to develop a computational method to predict the thermal dependence of xylanases. This tool was then implemented for targeted screening of putative xylanases with specific thermal dependencies from metagenomic data and resulted in the identification of three novel xylanases from sheep and cow rumen microbiota. Here we present thermal activity prediction for xylanase, a new sequence-based machine learning method that has been trained using a selected combination of various protein features. This random forest classifier discriminates non-thermophilic, thermophilic, and hyper-thermophilic xylanases. The model's performance was evaluated through multiple iterations of sixfold cross-validations as well as holdout tests, and it is freely accessible as a web-service at arimees.com.
Assuntos
Endo-1,4-beta-Xilanases , Temperatura Alta , Aprendizado de Máquina , Metagenoma , Microbiota , Rúmen/microbiologia , Animais , Bovinos/microbiologia , Endo-1,4-beta-Xilanases/química , Endo-1,4-beta-Xilanases/genética , Ovinos/microbiologiaRESUMO
Medication management is a complex process and is taken into account of daily activities. Moreover, participation in daily activities could define the wellbeing. On the other hand, the medication management process for visually impaired individuals is more difficult. Nowadays, the technologies like mHealth and RFID, have caused a significant progress in both areas of medication management systems and visually impaired Independent Living. Therefore the aim of this work was to develop an assistive medication management system for visually impaired people in order to improve the medication adherence among them. The development process started by requirements extraction according to goal directed design methodology introduced by Cooper. Then the system, called MedVision was developed, consisting of an android mobile application, RFID device and a medication box with vibration motors and it is developed for Iranian visually impaired individuals in Persian language. At the final step of this study, a functional assessment was performed in order to improve the system even more in next prototypes.